Pandemic blood shortages: a study to prepare for the next crisis
NCT ID NCT07490314
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study looked at how the COVID-19 pandemic affected the supply of blood products for emergency surgeries at one hospital. Researchers tracked delays and shortages from March 2020 to March 2021. The goal is to use this information to create better policies for handling blood shortages during future pandemics.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this could help hospitals create better plans to manage blood shortages during future pandemics.
- What could go wrong
- This is a small, single-hospital study that only looks back at past data, so its findings may not apply to other hospitals or future outbreaks.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for COVID-19 are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Methodist Dallas Medical Center- Clinical Research Institute
Dallas, Texas, 75203, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Brain fog after COVID: can two common drugs clear it?
- Could a five-day pill course cut COVID-19 deaths? czech nationwide data puts molnupiravir to the test.
- Can COVID-19 and emergency surgery be safely managed together? a massive hospital study seeks answers
- Text or call? study tests best way to boost COVID shots in schools
- Fish oil and Body's own healing molecules could lift long COVID depression
- 13,000 volunteers shed light on who gets sick from COVID-19